Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.5650
0.00 (0.00%)
Apr 17, 2025, 4:00 PM EDT - Market closed

MTNB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3347108218272
Upgrade
Market Cap Growth
-94.48%-94.48%-56.68%-50.35%-19.56%-26.50%
Upgrade
Enterprise Value
-1-53280169217
Upgrade
Last Close Price
0.600.5110.8125.0050.5068.00
Upgrade
PS Ratio
--42.8634.016618.481714.82
Upgrade
PB Ratio
0.400.342.442.964.164.26
Upgrade
P/TBV Ratio
0.400.342.623.074.274.63
Upgrade
EV/Sales Ratio
--29.6224.975133.741367.86
Upgrade
Debt / Equity Ratio
0.380.380.190.110.090.06
Upgrade
Asset Turnover
--0.030.0600.00
Upgrade
Quick Ratio
2.732.735.256.7111.4116.45
Upgrade
Current Ratio
3.013.015.938.0611.7317.25
Upgrade
Return on Equity (ROE)
-180.74%-180.74%-82.11%-47.12%-40.06%-46.39%
Upgrade
Return on Assets (ROA)
-66.77%-66.77%-42.49%-28.96%-23.37%-27.21%
Upgrade
Return on Capital (ROIC)
-75.72%-75.72%-46.74%-31.38%-24.80%-28.88%
Upgrade
Earnings Yield
-79454.40%-934.76%-48.84%-19.36%-10.66%-8.27%
Upgrade
FCF Yield
-52044.58%-612.29%-32.99%-18.49%-7.09%-6.40%
Upgrade
Buyback Yield / Dilution
-1197.90%-11.98%-0.21%-3.16%-6.75%-35.61%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q